Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: A multi-institutional cohort study

Shih Chieh Shao, Kai Cheng Chang, Ming Jui Hung, Ning I. Yang, Yuk Ying Chan, Hui Yu Chen, Yea Huei Kao Yang, Edward Chia Cheng Lai

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: A multi-institutional cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences